prof. dr. Marc Peeters

Jeroen Mertens (UGent) , SYLVIE DE BRUYNE (UGent) , Nancy Van Damme (UGent) , Peter Smeets (UGent) , Wim Ceelen (UGent) , Roberto Troisi (UGent) , Stéphanie Laurent (UGent) , Karen Geboes (UGent) , Marc Peeters (UGent) , Ingeborg Goethals (UGent) , et al.

(2013) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 40(8). p.1214-1222

Add to list

The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study

Daphne Hompes, André D'Hoore, Eric Van Cutsem, Steffen Fieuws, Wim Ceelen (UGent) , Marc Peeters (UGent) , Kurt Van der Speeten, Claude Bertrand, Hugues Legendre and Joseph Kerger

(2012) ANNALS OF SURGICAL ONCOLOGY. 19(7). p.2186-2194

Add to list

Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model

CHRISTEL VANGESTEL, Christophe Van De Wiele (UGent) , Gilles Mees (UGent) , Koen Mertens (UGent) , Steven Staelens (UGent) , Chris Reutelingsperger, Patrick Pauwels (UGent) , Nancy Van Damme (UGent) and Marc Peeters (UGent)

(2012) MOLECULAR IMAGING. 11(2). p.135-147

Add to list

A phase II randomized study of combined infusional leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer

H Bleiberg, A Vandebroek, I Deleu, P Vergauwe, HR Kalantari, G D'Haens, M Paesmans, Marc Peeters (UGent) , A Efira and Y Humblet

(2012) ACTA GASTRO-ENTEROLOGICA BELGICA. 75(1). p.14-21

Academic Bibliography

prof. dr. Marc Peeters

High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer

Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)

Children's International Polyposis (CHIP) study : a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer : the SIRFLOX study

Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study

Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases

The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study

Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model

A phase II randomized study of combined infusional leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer

Contents

Support

Contact